NDAORALTABLETPriority Review
Approved
Mar 2010
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Clinical Trials (5)
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Started Dec 2025
Rifaximin SSD in Dementia Trial
Started Dec 2024
Rifaximin for the Secondary Prevention of Recurrent Pouchitis
Started Jul 2024
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis
Started Aug 2022
Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
Started Jul 2022